| Variable | Definition | Type of Variable and Values |
|---|---|---|
| Demographics | ||
| Age | Age in years at hospital admission. | Continuous. Numerical. |
| Race | Race of the patient. | Categorical. Caucasian, Latin, or other. |
| Sex | Sex of patient at birth. | Categorical. Male or female. |
| Comorbidities | ||
| Age-adjusted Charlson index | Charlson Comorbidity Index calculated at hospital admission, based on comorbidity previously reported in medical history adjusted for age. | Continuous. Numerical, 0–48. |
| AMI | If acute myocardial infarction was previously reported in the medical history. | Categorical. Yes or no. |
| Alcohol abuse | If alcohol abuse was reported in the medical history. | Categorical. Yes or no. |
| Angina | If angina was previously reported in the medical history. | Categorical. Yes or no. |
| Asthma | If asthma was previously reported in the medical history. | Categorical. Yes or no. |
| Atrial fibrillation | If atrial fibrillation was previously reported in the medical history. | Categorical. Yes or no. |
| Cancer | If active cancer was reported in the medical history. | Categorical. Yes or no. |
| Comorbidity | Age-adjusted Charlson score value ≥ 3 | Categorical. Yes or no. |
| COPD | If chronic obstructive pulmonary disease was previously reported in the medical history. | Categorical. Yes or no. |
| Dependence status | What was the degree of dependence before hospital admission reported in the medical history according to the Barthel index? | Categorical. Absent or mild dependence, moderate dependence, or severe dependence. |
| Depression | If chronic depression was previously reported in the medical history. | Categorical. Yes or no. |
| CHF | If chronic heart failure was previously reported in the medical history. | Categorical. Yes or no. |
| CHT | If chronic hypertension was previously reported in the medical history. | Categorical. Yes or no. |
| CKD | If chronic kidney disease, defined as MDRD4 <60 mL/min (1.73 m2), was previously reported in the medical history. | Categorical. Yes or no. |
| CLD | If chronic liver disease was previously reported in the medical history. | Categorical. Yes or no. |
| CTD | If a connective tissue disease (e.g., systemic lupus erythematosus and scleroderma) was previously reported in the medical history. | Categorical. Yes or no. |
| DM | If diabetes mellitus was previously reported in the medical history. | Categorical. Yes or no. |
| Dyslipidemia | If dyslipidemia was previously reported in the medical history. | Categorical. Yes or no. |
| IS | If ischemic stroke was previously reported in the medical history. | Categorical. Yes or no. |
| Neurodegenerative disease | If a neurodegenerative disease (e.g., Alzheimer disease, Parkinson disease, and Huntington disease) was previously reported in the medical history. | Categorical. Yes or no. |
| Obesity | If obesity, defined as a body mass index >30 kg/m2, was previously reported in the medical history. | Categorical. Yes or no. |
| OSAS | If obstructive sleep apnea syndrome was previously reported in the medical history. | Categorical. Yes or no. |
| PVD | If peripheral vascular disease was previously reported in the medical history. | Categorical. Yes or no. |
| Smoking | If smoking was previously reported in the medical history. | Categorical. Never smoked, former smoker, or current smoker. |
| TIA | If transient ischemic accident was previously reported in the medical history. | Categorical. Yes or no. |
| Baseline pharmacological treatments | ||
| ACEi | If maintained use of angiotensin-converting enzyme inhibitors was previously reported in the medical history. | Categorical. Yes or no. |
| Acenocoumarol | If maintained use of acenocoumarol was previously reported in the medical history. | Categorical. Yes or no. |
| ARB | If maintained use of angiotensin receptor blockers was previously reported in the medical history. | Categorical. Yes or no. |
| Aspirin | If maintained use of aspirin was previously reported in the medical history. | Categorical. Yes or no. |
| Direct anticoagulants | If maintained use of direct anticoagulants was previously reported in the medical history. | Categorical. Yes or no. |
| DPP4i | If maintained use of dipeptidyl peptidase-4 inhibitors was previously reported in the medical history. | Categorical. Yes or no. |
| Inhaled corticosteroids | If maintained use of inhaled corticosteroids was previously reported in the medical history. | Categorical. Yes or no. |
| Insulin | If maintained use of insulin was previously reported in the medical history. | Categorical. Yes or no. |
| LMWH | If maintained use of low-molecular-weight heparin was previously reported in the medical history. | Categorical. Yes or no. |
| Metformin | If maintained use of metformin was previously reported in the medical history. | Categorical. Yes or no. |
| Monoclonal antibodies | If maintained use of monoclonal antibodies was previously reported in the medical history. | Categorical. Yes or no. |
| SGLT2i | If maintained use of sodium-glucose transporter (SGLT) 2 inhibitors was previously reported in the medical history. | Categorical. Yes or no. |
| Statins | If maintained use of statins was previously reported in the medical history. | Categorical. Yes or no. |
| Systemic corticosteroids | If maintained use of systemic corticosteroids was previously reported in the medical history. | Categorical. Yes or no. |
| COVID-19-related variables | ||
| General variables | ||
| Origin of infection | Suspected site of infection. | Categorical. Community, healthcare staff, or others. |
| Duration of symptoms | Days since onset of symptoms until admission. | Numerical. Days. |
| Clinical manifestations | ||
| Abdominal pain | If abdominal pain was present at admission or during the days before according to the medical history. | Categorical. Yes or no. |
| Ageusia | If ageusia was present at admission or during the days before according to the medical history. | Categorical. Yes or no. |
| Anosmia | If anosmia was present at admission or during the days before according to the medical history. | Categorical. Yes or no. |
| Anorexia | If anorexia was present at admission or during the days before according to the medical history. | Categorical. Yes or no. |
| Asthenia | If asthenia was present at admission or during the days before according to the medical history. | Categorical. Yes or no. |
| Cough | If cough was present at admission or during the days before according to the medical history. | Categorical. No cough, dry cough, or wet cough. |
| Diarrhea | If diarrhea was present at admission or during the days before according to the medical history. | Categorical. Yes or no. |
| Dyspnea | If dyspnea was present at admission or during the days before according to the medical history. | Categorical. Yes or no. |
| Headache | If headache was present at admission or during the days before according to the medical history. | Categorical. Yes or no. |
| Myalgia | If myalgia was present at admission or during the days before according to the medical history. | Categorical. Yes or no. |
| Nausea | If nausea was present at admission or during the days before according to the medical history. | Categorical. Yes or no. |
| Odynophagia | If odynophagia was present at admission or during the days before according to the medical history. | Categorical. Yes or no. |
| Vomiting | If vomiting was present at admission or during the days before according to the medical history. | Categorical. Yes or no. |
| Physical examination at admission | ||
| Baseline O2 saturation | Oxygen saturation, in percentage, at hospital admission, without supplementary oxygen therapy. | Continuous. Numerical. |
| Baseline O2 saturation < 93% | If oxygen saturation without supplementary oxygen at hospital admission was less than 93%. | Categorical. Yes or no. |
| Confusion | If confusion was present at admission or during the days before, according to the medical history. | Categorical. Yes or no. |
| Crackles | If crackles were present at admission. | Categorical. Yes or no. |
| DBP | Diastolic blood pressure, in millimeters of mercury, at hospital admission. | Continuous. Numerical. |
| Heart rate | Heart rate, in beats per minute, at hospital admission. | Continuous. Numerical. |
| SBP | Systolic blood pressure, in millimeters of mercury, at hospital admission. | Continuous. Numerical. |
| Tachypnea | If tachypnea, defined as breathing rate greater than 22 breaths per minute, was present at admission according to the medical history. | Categorical. Yes or no. |
| Rhonchi | If rhonchi were present at hospital admission. | Categorical. Yes or no. |
| Temperature | Temperature, in degrees Celsius, at hospital admission. | Continuous. Numerical. |
| Temperature ≥ 38 °C | If temperature at hospital admission was greater than 38 °C. | Categorical. Yes or no. |
| Wheezing | If wheezing was present at hospital admission. | Categorical. Yes or no. |
| Radiological findings | ||
| Alveolar condensation | Alveolar condensation in the plain chest radiograph at admission. | Categorical. Absent, unilateral, or bilateral. |
| Interstitial infiltrate | Interstitial infiltrate in the plain chest radiograph at admission. | Categorical. Absent, unilateral, or bilateral. |
| Pleural effusion | Pleural effusion in the plain chest radiograph at admission. | Categorical. Absent, unilateral, or bilateral. |
| Analytical findings | ||
| Albumin | Value of serum albumin at admission in g/dL. | Continuous. Numerical. |
| Creatinine | Value of plasma creatinine at admission in mg/dL. | Continuous. Numerical. |
| CRP | Value of C-reactive protein at admission in mg/L. | Continuous. Numerical. |
| Glucose | Value of plasma glucose at admission in mg/dL. | Continuous. Numerical. |
| Leukocytes | Number of leukocytes’ 106 per liter at hospital admission. | Continuous. Numerical. |
| Hemoglobin | Value of hemoglobin at admission in g/dL. | Continuous. Numerical. |
| Lymphocytes | Number of lymphocytes’ 106 per liter at hospital admission. | Continuous. Numerical. |
| Neutrophils | Number of neutrophils’ 106 per liter at hospital admission. | Continuous. Numerical. |
| Platelets | Number of platelets’ 106 per liter in blood test at hospital admission. | Continuous. Numerical. |
| Plasma sodium | Value of plasma sodium at admission in mEq/L. | Continuous. Numerical. |
| Plasma potassium | Value of plasma potassium at admission in mEq/L. | Continuous. Numerical. |
| Outcomes | ||
| In-hospital mortality | If the patient died during hospitalization due to SARS-CoV-2 infection, or 30 days after hospital discharge. | Categorical. Yes or no. |
| Length of stay | More or less than 14 days. | Categorical. Yes or no. |
| Need for NIMV | If during hospitalization the patient has received continuous positive airway pressure (CPAP) and/or bilevel positive airway pressure (BiPAP) and/or high-flow cannula oxygen therapy. | Categorical. Yes or no. |
| ICU admission | If the patient has required admission to the intensive care unit. | Categorical. Yes or no. |